Current:Home > ContactThis drug is the 'breakthrough of the year' — and it could mean the end of the HIV epidemic -Thrive Capital Insights
This drug is the 'breakthrough of the year' — and it could mean the end of the HIV epidemic
View
Date:2025-04-13 13:55:57
Can we eliminate the HIV epidemic?
It's a question that dates back to the start of the epidemic in the 1980s. With 1.3 million new infections a year, the epidemic continues … and the world is not on track to meet the ambitious U.N. goal of ending HIV/AIDS by 2030.
But 2024 has fueled increasing optimism among leading infectious disease experts after the results of two groundbreaking clinical trial results for a drug called lenacapavir showed it to be capable of virtually eliminating new HIV infections through sex.
The emerging data surrounding lenacapavir is so astonishing that the drug's development has been heralded as the 2024 Breakthrough of the Year by the journal Science,which described it as representing "a pivotal step toward diminishing HIV/AIDS as a global health crisis."
veryGood! (65144)
Related
- The Best Stocking Stuffers Under $25
- Ulta & Sephora 1-Day Deals: 50% Off Lancome Monsieur Big Volumizing Mascara, MAC Liquid Lipstick & More
- Watch: Astros' Jose Altuve strips down to argue with umpire over missed call
- Florence Pugh Addresses Nasty Comments About Her Weight
- Illinois governor calls for resignation of sheriff whose deputy fatally shot Black woman in her home
- People We Meet on Vacation Cast Revealed for Emily Henry Book's Movie Adaptation
- KIND founder Daniel Lubetzky joins 'Shark Tank' for Mark Cuban's final season
- Tyler Henry on Netflix's 'Live from the Other Side' and the 'great fear of humiliation'
- Retirement planning: 3 crucial moves everyone should make before 2025
- Oversight board says it will help speed up projects to fix Puerto Rico’s electric grid
Ranking
- Euphoria's Hunter Schafer Says Ex Dominic Fike Cheated on Her Before Breakup
- Wagon rolls over at Wisconsin apple orchard injuring about 25 children and adults
- KIND founder Daniel Lubetzky joins 'Shark Tank' for Mark Cuban's final season
- Florence Pugh Addresses Nasty Comments About Her Weight
- Carolinas bracing for second landfall from Tropical Storm Debby: Live updates
- Lionel Messi, Inter Miami back in action vs. Atlanta United: Will he play, time, how to watch
- USWNT loses to North Korea in semifinals of U-20 Women's World Cup
- Georgia Sen. Jon Ossoff seeks more control over postmaster general after mail meltdown
Recommendation
USA men's volleyball mourns chance at gold after losing 5-set thriller, will go for bronze
Off the Grid: Sally breaks down USA TODAY's daily crossword, It Started With the Wine
Review: Marvel's 'Agatha All Along' has a lot of hocus pocus but no magic
North Carolina’s highest court hears challenge to law allowing more time for child sex abuse suits
Costco membership growth 'robust,' even amid fee increase: What to know about earnings release
What NFL games are today: Schedule, time, how to watch Thursday action
Jimmy Carter receives Holbrooke award from Dayton Literary Peace Prize Foundation
KIND founder Daniel Lubetzky joins 'Shark Tank' for Mark Cuban's final season